Respiratory Infections Can Reactivate Dormant Breast Cancer Cells in the Lungs
New studies reveal that respiratory viruses like COVID-19 and influenza can awaken dormant breast cancer cells in the lungs, increasing metastasis risk in cancer survivors. Insights from mouse models and population data suggest immune responses, particularly IL-6, play a key role, highlighting the importance of preventive measures and targeted therapies.
Recent research conducted by teams at the University of Colorado Anschutz Medical Campus, Montefiore Einstein Comprehensive Cancer Center, and Utrecht University has uncovered compelling evidence that common respiratory viruses, including COVID-19 and influenza, may have the potential to reactivate dormant breast cancer cells that have spread to the lungs. This awakening of silent cancer cells can lead to the formation of new metastatic tumors, posing increased risks for cancer survivors.
Published in the journal Nature, the study utilized mouse models to simulate the metastatic process in humans. The researchers observed that respiratory infections triggered an immune response involving interleukin-6 (IL-6), a protein that promotes inflammation. Elevated levels of IL-6 appear to awaken dormant disseminated cancer cells (DCCs) in the lungs, which then rapidly expand into detectable metastatic lesions within days.
The findings are supported by epidemiological data showing that cancer patients who contracted COVID-19 experienced higher rates of cancer progression and death. Specifically, large population studies from the UK Biobank and the U.S. Flatiron Health database revealed that cancer survivors infected with respiratory viruses had nearly doubled risks of metastatic relapse, particularly soon after infection.
Dr. Julio Aguirre-Ghiso emphasized the importance of precautions for cancer survivors, recommending vaccinations and close discussions with healthcare providers. Meanwhile, the research team highlighted that IL-6 inhibitors or other immunotherapies could potentially prevent dormant cancer cells from reactivating during infections.
This multidisciplinary study underscores the long-term impact of respiratory viruses on cancer progression, especially in individuals in remission. It also points to potential therapeutic strategies to mitigate metastasis risk caused by common respiratory illnesses.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
FDA Limits Access to Updated COVID Vaccines Amid Regulatory Changes
The FDA has approved updated COVID-19 vaccines for this season but has restricted eligibility, raising concerns about potential increases in COVID-19 cases and tensions over vaccine policies.
Australian School-Based Program Significantly Cuts Teen Vaping Rates by 65%
A pioneering school-based vaping prevention program in Australia has reduced teenage vaping by 65%, emphasizing the importance of interactive education in youth health initiatives.
Study Reveals One in Three People Avoid Learning About Serious Health Risks
A new study shows that one in three individuals avoid learning about serious health risks due to fear and mistrust in the healthcare system, impacting early detection and treatment.
Common Biomarker Profile Found Across Major Neurodegenerative Disorders
A groundbreaking study has identified a shared five-protein biomarker profile across major neurodegenerative diseases, opening new avenues for diagnosis and treatment strategies.